secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2023-09-20T23:59:59+00:00
Accession:  0001493152-23-033143
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte subleases 13,400 sq ft of Irvine office to Induce Biologics
--------------------------------------------------------------------

- Sublease covers initially 13,400 sq ft, expanding to full ~26,800 sq ft after 18 months.
- Monthly base rent starts at $36,850, escalating to $80,534 by 2027; term ends Oct 31, 2027.
- Subtenant pays a $101,987 security deposit and 50% of expenses/taxes during initial period.
- Sublease became effective Sept 14, 2023 after landlord consent; commencement 120 days later.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000149315223033143/0001493152-23-033143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000149315223033143/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-033143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer